This is an open follow-up clinical trials to evaluate a sustained efficacy and safety of Adipoplus inj. for 10 months (12 months after final dose injection)after Phase II clinical trial.
Study Type
OBSERVATIONAL
Enrollment
37
DaeHang Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul Asan Hospital
Seoul, South Korea
Number of patients with Sustained efficacy of complete closure of fistula
Proportion of patients whose fistula has been completely closed.
Time frame: Month 4, 10
Number of patients with sustained efficacy of closure of fistula
Proportion of patients with more than 50% closed of fistula (Month 2, 4, 10)
Time frame: Month 2, 4, 10
Number of patients with any adverse event
number of patients with any adverse event (Month 2, 4, 10)
Time frame: Month 2, 4, 10
Grade of Investigator's satisfaction
Grade of Investigator's satisfaction (Month 2, 4, 10) 1. very satisfaction 2. satisfacttion 3. somewhat satisfaction 4. unsatisfaction 5. very unsatisfaction
Time frame: Month 2, 4, 10
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.